Western blot analysis demonstrates that BIX-01294 (0, 5, 10 μmol/l) significantly activated CASP8, CASP9, CASP3 and cleaved the substrate of CASP3, PARP1 in bladder cancer cells treated for 24 hours (Figure 1B). This evidence concerns the gene CASP8 and urinary bladder carcinoma.